There is a concerted effort by a number of public and private groups to identify a large set of human single-nucleotide polymorphisms1,2 (SNPs). As of March 2001, 2.84 million SNPs have been ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...